Epilepsy Studies

An International, Double-Blind, Parallel-Group, Placebo-Controlled, Randomized Study: Evaluation of the Efficacy and Safety of Brivaracetam in Subjects (> 16 to 70 years old) with Partial Onset Seizures.

The main purpose of this study is to find out how safe and effective different doses of brivaracetam are in reducing the frequency of seizures in patients who have partial onset seizures.

Qualified participants must be:

• between 16 and 70 years of age
• experiencing partial onset seizures and are regularly taking one or two other antiepileptic drugs.

Please see the bottom of this page for contact information.

Having Uncontrolled Seizures?

The University of Arizona - Department of Neurology is evaluating an investigational medication, called E2080 (also known as Rufinamide) to help reduce seizure frequency.

This study will investigate whether E2080 will help people with partial-onset seizures who are already taking other seizure medications. The study doctor wants to research whether people who add E2080 to their regular antiepileptic drug regimens have fewer seizures than people who don’t add anything to their regular antiepileptic drug regimens.

Qualified participants must be:

• between 12 and 80 years of age
• in general good health
• diagnosed with epilepsy with partial-onset seizures
• non-controlled partial seizures despite having been treated with at least two different antiepileptic drugs for at least two years

If you qualify for participation, all study-related medical care, physical exams, lab tests and investigational drug will be provided at no cost.

Please see the bottom of this page for contact information.

Are cluster or breakthrough seizures, also known as Acute Repetitive Seizures, affecting your life? Do these seizures happen quickly over a short period of time?

If so, you may be eligible to participate in a clinical trial to evaluate a drug delivery system being studied for repetitive seizures. Adults and children (age 2 and up) with epilepsy may qualify. An adult caregiver is required for participation. Participants will receive study medication, study-related procedures and study visits at no cost. Caregivers will be trained on how to deliver the study medication.

Please see the bottom of this page for contact information.

If you are interested in seeing if someone you know is eligible to participate in any of these studies or if you just want more information, please contact:

Susan Merski, BSN, RN
Research Nurse, Sr.
(520) 626-4296

Lynda Seal, BSN, RN
Research Nurse, Sr.
(520) 626-0868

University of Arizona, Health Science Center, Department of Neurology
1501 N. Campbell Avenue, Room 7329
Tucson, AZ 85724-5023
Fax: 520-626-4903